TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02195726

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Description: four times 5-minute inflations of a blood pressure cuff to 200 mmHg around the upper non dominant arm (or if systolic pressure is more than 150 mmHg, inflation will reach 50 mmHg up per than baseline), followed by 5-minute intervals of reperfusion.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham remote ischemic preconditioning
Description: In the control group sham preconditioning will be performed with inflation of 10 mmHg more than baseline.
Study: NCT00426660

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: maraviroc
Description: The nominal dose for maraviroc is 300 mg twice a day (BID). However, the dosage of maraviroc should be adjusted based on optimal background therapy (OBT) patient is taking. If OBT includes CYP3A4 inhibitor (with or without inducers) maraviroc dose should be 150 mg BID and if OBT includes CYP3A4 inducer (without inhibitors) maraviroc dose should be 600mg BID. If OBT does not include any CYP3A4 inducers or inhibitors maraviroc dose should be 300 mg BID.
Study: NCT02565706

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: WIC Fresh Start Program
Description: The intervention is an online lesson to promote farmers' market FV purchases and consumption. The lesson comprises three modules, each consisting of 1) behavior change content presented through a video segment featuring WIC participants, and 2) an interactive activity to build targeted knowledge, attitudes, and skills.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: WIC Fresh Start Program
Description: The intervention is an online lesson to promote farmers' market FV purchases and consumption. The lesson comprises three modules, each consisting of 1) behavior change content presented through a video segment featuring WIC participants, and 2) an interactive activity to build targeted knowledge, attitudes, and skills.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Existing Online Health Education
Description: Any of seven existing online WIC health education lessons (lessons are available on breastfeeding, being active, fruits and vegetables, calcium, cholesterol, oral health and iron). The lessons consist of an introductory segment presented with online text and graphics. After reading this material, viewers have the option to complete one of four lesson activities. The activities provide opportunities for viewers to read further on the topic and are designed to reinforce key points of the lesson.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Existing Online Health Education
Description: Any of seven existing online WIC health education lessons (lessons are available on breastfeeding, being active, fruits and vegetables, calcium, cholesterol, oral health and iron). The lessons consist of an introductory segment presented with online text and graphics. After reading this material, viewers have the option to complete one of four lesson activities. The activities provide opportunities for viewers to read further on the topic and are designed to reinforce key points of the lesson.
Study: NCT03755518

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FEDRATINIB
Description: A potent and selective inhibitor of JAK2 kinase activity
Study: NCT04030325

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sequential Personalized Feedback Intervention Delivery
Description: Sequential PFI delivery over 3 weeks after baseline survey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sequential Personalized Feedback Intervention Delivery
Description: Sequential PFI delivery over 3 weeks after baseline survey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simultaneous Personalized Feedback Intervention Delivery
Description: Simultaneous PFI delivery after baseline survey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Simultaneous Personalized Feedback Intervention Delivery
Description: Simultaneous PFI delivery after baseline survey

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text Message Boosters
Description: Text message boosters on PFI content during week of high risk drinking events

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text Message Boosters
Description: Text message boosters on PFI content during week of high risk drinking events
Study: NCT02093390

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-385
Description: TAK-385 tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TAK-385
Description: TAK-385 tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluconazole
Description: Fluconazole tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Atorvastatin tablets
Study: NCT02193711

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Topical Arthritis Cream

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical Arthritis Cream
Study: NCT00006305

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions
Description: Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions
Description: Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Artery Bypass
Description: Coronary Artery Bypass

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary Artery Bypass
Description: Coronary Artery Bypass

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Biguanides, thiazolidinediones
Description: Biguanides, thiazolidinediones
Study: NCT04213820

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation
Description: TMS (theta burst) will be administered consisting of bursts containing 3 pulses at 50 Hz and an intensity of 80% motor threshold repeated at 200 ms intervals (i.e., at 5 Hz) and a 10 s between burst triplet interval for a total for 190 s (600 pulses). The intervention will be given daily 5 times/week during 4 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Body Image Intervention
Description: Body image interventions delivered directly after TMS will include body exercises that target disturbed body image and psychoeducation about the body. Together with a therapist the participants with anorexia nervosa will explore and estimate their body size through feedback.
Study: NCT00006305

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Biguanides, thiazolidinediones
Description: Biguanides, thiazolidinediones

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin, sulfonylurea
Description: Insulin, sulfonylurea

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin, sulfonylurea
Description: Insulin, sulfonylurea

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Description: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Description: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Description: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Study: NCT00981825

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triclosan/Fluoride
Description: Brush whole mouth twice daily for 7 days
Study: NCT00305864

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo radiotherapy

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo radiotherapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Motexafin Gadolinium
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Motexafin Gadolinium
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Motexafin Gadolinium
Description: Given IV

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Motexafin Gadolinium
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given orally

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temozolomide
Description: Given orally
Study: NCT02666963

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 901 Capsules, 10 or 40 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RTA 901 Capsules, 10 or 40 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Study: NCT01700673

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine will be administered days 1-5 of a 28 day cycle. Treatment is planned for a total of 12 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine will be administered days 1-5 of a 28 day cycle. Treatment is planned for a total of 12 cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine will be administered days 1-5 of a 28 day cycle. Treatment is planned for a total of 12 cycles.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sargramostim
Description: Sargramostim will be administered days 1-10 of a 28 day cycle. Treatment is planned for a total of 12 cycles.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sargramostim
Description: Sargramostim will be administered days 1-10 of a 28 day cycle. Treatment is planned for a total of 12 cycles.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sargramostim
Description: Sargramostim will be administered days 1-10 of a 28 day cycle. Treatment is planned for a total of 12 cycles.
Study: NCT03881059

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: BMS-986165 Placebo
Description: Participants will receive BMS-986165 matching placebo QD
Study: NCT00006305

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Description: ACE Inhibitors, Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers
Study: NCT01920659

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Training (HIT)
Description: 6 weeks of HIT, 3 times a week (3-5 1min on/off)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REHIT
Description: 6 weeks 3 x week (20sec intervals)
Study: NCT01413074

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis treatment
Description: PD treatment

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hemodialysis treatment
Description: HD treatment
Study: NCT04375501

Intervention type: OTHER
Intervention: Surgery: Dynamic Hip Screw, hemiarthroplasty, hip replacement, intramedullary nail
Description: If fit for anaesthesia patients may undergo relevant procedure for fractured neck of femur as per NICE guidelines within limitations of resources as defined by BOAST
Study: NCT04213820

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Body Image Intervention
Description: Body image interventions delivered directly after TMS will include body exercises that target disturbed body image and psychoeducation about the body. Together with a therapist the participants with anorexia nervosa will explore and estimate their body size through feedback.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Treatment as usual at the eating disorder unit, Child and adolescent psychiatric clinic and Psychiatric clinic is delivered during 4 weeks
Study: NCT02735356

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Applied topically
Study: NCT01199822

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Olaratumab
Description: Cohort 1 10 milligrams/kilogram (mg/kg) intravenously (IV) administered on Days 1 and 8, every 3 weeks; Cohort 2 20 mg/kg IV administered every 2 weeks; Cohort 3 15 mg/kg IV administered on Days 1 and 8, every 3 weeks
Study: NCT03368404

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CBL-102 eye drops
Description: CBL-102 eye drops, 3 to 6 times per day for 3 months

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Vismed Multi eye drops
Description: Vismed Multi eye drops, 3 to 6 times per day for 3 months
Study: NCT04653623

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: High tibial osteotomy
Description: Treatment option for medial compartment osteoarthritis of knee

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High tibial osteotomy
Description: Treatment option for medial compartment osteoarthritis of knee

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: Medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation
Study: NCT03595865

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tafluprostin
Description: Both patients in PACG and POAG groups will dose 1 time daily in each eye for 6months. Each eye will be preformed tafluprostin 0.0015% at 9 PM.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tafluprostin
Description: Both patients in PACG and POAG groups will dose 1 time daily in each eye for 6months. Each eye will be preformed tafluprostin 0.0015% at 9 PM.
Study: NCT02732327

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CAZ-AVI
Description: Ceftazidime-Avibactam (2 g ceftazidime and 0.5 g avibactam)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vancomycin
Description: 15 mg/kg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vancomycin
Description: 15 mg/kg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linezolid
Description: 600 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Linezolid
Description: 600 mg

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cefepime
Description: 2 g

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Meropenem
Description: 1 g

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Piperacillin/tazobactam
Description: 4.5 g
Study: NCT04020081

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga breathing exercises and Meditation
Description: 8 Breathing exercises.The first set of 6 exercises is of the Upper Lobe breathing (Upper and Middle Lobe of the Lungs) while 7th exercise is abdominal breathing,8th exercise is yogic breathing.~6-steps Nirmal Dhyan (meditation).Step 1: Breath awareness,Step 2: Body awareness,Step 3: Thought awareness,Step 4: Refreshing awareness,Step 5: Gap awareness,Step 6: Expanding awareness.
Study: NCT00204477

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: soy milk
Description: Each drink contained soy protein, fat, and carbohydrates calcium and phosphorous to give a total energy of 177.8 kcal. Subjects took two drinks per day.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: cow's milk
Description: Each drink contained casein, fat, carbohydrates, calcium and phosphorous to give a total energy of 178.6 kcal. Subjects took two drinks per day.
Study: NCT05353634

Intervention type: DIAGNOSTIC_TEST
Intervention: Effects of mNGS on infected patients
Description: The impact of mNGS on infected patients, including diagnostic value, drug selection, treatment prognosis, economic burden, etc.

Intervention type: DIAGNOSTIC_TEST
Intervention: Effects of mNGS on infected patients
Description: The impact of mNGS on infected patients, including diagnostic value, drug selection, treatment prognosis, economic burden, etc.
Study: NCT04621643

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: digital cognitive behavioral therapy (dCBT-I)
Description: dCBT-I during 9 weeks. Multicomponent intervention that includes the following: psychoeducation about sleep, sleep hygiene, sleep restriction therapy, stimulus control and challenging beliefs and perception about sleep. The digital CBT-I that will be utilized in this study is named Sleep Healthy Using The internet (SHUTi). The intervention is fully automated with no contact with health care personnel, it is interactive and adapts to input from the users. It comprises of the same elements included in face-to-face CBT-I, but the user gains access to a new educational, behavioral or cognitive module each week only after completion of digital sleep diaries. dCBT-I can be accessed on computers or hand-held devices

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital patient education about insomnia (PE)
Description: Control condition PE during 9 weeks. A digital patient education program that can be accessed on computers or hand-held devices. The information overlaps with that included in the dCBT-I intervention but it does not include any of the interactive features of the dCBT-I intervention and all the information is available from the moment the PE site is opened.
Study: NCT01430624

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PPRS
Description: Video including information psychoeducation and modeling of adaptive behavioral coping strategies for use post-assault. Shown at time of post assault medical exam.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PIRI
Description: Video containing pleasant imagery and relaxation instruction information. Shown at time of post assault medical exam.
Study: NCT01761305

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hypercorrective night-time brace
Description: Hypercorrective night-time brace worn 8 hours per night. Patients are encouraged to also continue with non-specific self-mediated physical activities of moderate intensity at least 60 minutes daily, for the entirety of the study. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. A training diary will be implemented to follow and motivate the patient's training behaviour.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scoliosis specific exercises.
Description: The intervention will be delivered in 3 x 90 minute sessions, once per month during the first 3 months. Goals are directed towards active self-correction and postural control, spinal stability, aerobic functioning and development of a positive body image. Additional postural specific exercises including self-mediated hyper-corrective exercises are to be performed with moderate intensity at least for 30 minutes at least 2-3 times per week. Other physical activities to fulfill the general recommended quota of more than 60 minutes moderate intensity physical activity per day are recommended. Reinforcement of the intervention will be performed in conjunction with reassessment every 6 months. A training diary will be implemented to follow and motivate the patient's training behaviour.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-mediated physical activity.
Description: Instructions for self-mediated physical activity will be delivered during a 1 hour session. Patients are encouraged to perform self-mediated physical activities of moderate intensity at least 60 minutes daily, for the entirety of the study. Reinforcement of the assigned intervention will be performed in conjunction with reassessment every 6 months. A training diary will be implemented to follow and motivate the patient's training behaviour.
Study: NCT03217019

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guidewire-assist
Description: catheter insertion with guidewire-assist(catheter over guidewire)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Direct
Description: catheter insertion without guidewire assist(catheter over needle)
Study: NCT02320227

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Miami w/o frag Personal lubricant
Study: NCT05270915

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family supportive care in EOLC
Description: The investigators designed a separated single-bedded EOLC room for the infant and parents. Other family members, such as grandparents or siblings, were allowed to visit the infant and parents. The design of the room included the option for parents to stay comfortably on a sofa to relax and to play soothing music. Parents were encouraged to stay as long as they want and participate in basic care including physical contact with their infant. The nurses supported the parents in creating commemorative items such as a 'Yuan man' box with photos, baby handprint cards, footprint cards, a lock of hair and other precious memory items. A psychologist, in collaboration with our NICU, and a neonatologist supported the parents by individual interviews.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Family supportive care in EOLC
Description: The investigators designed a separated single-bedded EOLC room for the infant and parents. Other family members, such as grandparents or siblings, were allowed to visit the infant and parents. The design of the room included the option for parents to stay comfortably on a sofa to relax and to play soothing music. Parents were encouraged to stay as long as they want and participate in basic care including physical contact with their infant. The nurses supported the parents in creating commemorative items such as a 'Yuan man' box with photos, baby handprint cards, footprint cards, a lock of hair and other precious memory items. A psychologist, in collaboration with our NICU, and a neonatologist supported the parents by individual interviews.